Find Articles



Return to:Anxiety Articles
Or:Recent Anxiety Articles

Synosia says epilepsy drug rufinamide shown promising as mood disorder ...


http://www.cnbc.com/id/22776484/for/cnbc

CNBC - The study has also helped us select a dose for our Phase 2 trial in general anxiety disorder scheduled to start in the United States later this year." tf.TFN-Europe_newsdesk@thomson.com hjp/jlw COPYRIGHT Copyright Thomson Financial News Limited ...



Article Finder:

January 21, 2008 11:47:00 PM
Article Directory